Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Prospective surveillance study of invasive pneumococcal disease among urban children in the Philippines.

Capeding MR, Bravo L, Santos J, Kilgore PE, Kim SA, Balter I, Hubler R, Ye J, Moscariello M.

Pediatr Infect Dis J. 2013 Oct;32(10):e383-9. doi: 10.1097/INF.0b013e318298dfd5.

PMID:
23629024
2.

Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia.

Benavides JA, Ovalle OO, Salvador GR, Gray S, Isaacman D, Rodgers GL.

Vaccine. 2012 Aug 31;30(40):5886-92. doi: 10.1016/j.vaccine.2012.03.054. Epub 2012 Apr 4.

PMID:
22484295
3.

Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San José, Costa Rica.

Arguedas A, Abdelnour A, Soley C, Jimenez E, Jimenez AL, Ramcharran D, Porat N, Dagan R, Gray S, Rodgers GL.

Vaccine. 2012 Mar 16;30(13):2342-8. doi: 10.1016/j.vaccine.2012.01.047. Epub 2012 Jan 30.

PMID:
22300725
4.

Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.

Hsu KK, Shea KM, Stevenson AE, Pelton SI; Massachusetts Department of Public Health.

Pediatr Infect Dis J. 2010 Apr;29(4):289-93. doi: 10.1097/INF.0b013e3181c15471.

PMID:
19935447
5.

The status of invasive pneumococcal disease among children younger than 5 years of age in north-west Lombardy, Italy.

Riva E, Salvini F, Garlaschi ML, Radaelli G, Giovannini M.

BMC Infect Dis. 2012 May 3;12:106. doi: 10.1186/1471-2334-12-106.

6.

Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.

Hanna-Wakim R, Chehab H, Mahfouz I, Nassar F, Baroud M, Shehab M, Pimentel G, Wasfy M, House B, Araj G, Matar G, Dbaibo G; Lebanese Inter-Hospital Pneumococcal Surveillance Program.

Vaccine. 2012 Dec 31;30 Suppl 6:G11-7. doi: 10.1016/j.vaccine.2012.07.020.

PMID:
23228352
7.

Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.

Arifeen SE, Saha SK, Rahman S, Rahman KM, Rahman SM, Bari S, Naheed A, Mannan I, Seraji MH, Ahmed NU, Hassan MS, Huda N, Siddik AU, Quasem I, Islam M, Fatima K, Al-Emran H, Brooks WA, Baqui AH, Breiman RF, Sack D, Luby SP.

Clin Infect Dis. 2009 Mar 1;48 Suppl 2:S103-13. doi: 10.1086/596543.

PMID:
19191605
8.
9.

Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Goiânia, Brazil.

Andrade AL, Oliveira R, Vieira MA, Minamisava R, Pessoa V Jr, Brandileone MC, Alves SL, Alfieri F, Pagliarini R, Moraes JC, Gray S, Rodgers GL.

Vaccine. 2012 Feb 27;30(10):1901-9. doi: 10.1016/j.vaccine.2011.12.012. Epub 2011 Dec 15.

PMID:
22178522
11.

Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States.

Rosen JB, Thomas AR, Lexau CA, Reingold A, Hadler JL, Harrison LH, Bennett NM, Schaffner W, Farley MM, Beall BW, Moore MR; CDC Emerging Infections Program Network.

Clin Infect Dis. 2011 Jul 15;53(2):137-43. doi: 10.1093/cid/cir326.

PMID:
21690620
12.

Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.

Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP.

Pediatr Infect Dis J. 2007 Sep;26(9):771-7.

PMID:
17721369
13.

Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.

dos Santos SR, Passadore LF, Takagi EH, Fujii CM, Yoshioka CR, Gilio AE, Martinez MB.

Vaccine. 2013 Dec 9;31(51):6150-4. doi: 10.1016/j.vaccine.2013.05.042. Epub 2013 Jun 6.

14.
15.

Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.

Watson M, Bayley K, Bell JM, Gilbert GL, Hogg G, Keil AD, Krause V, Murphy D, Roche P, Smith HV, Stewart MG, Stylianopoulos J, Turnidge J.

Commun Dis Intell Q Rep. 2003;27(4):478-87.

16.

Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.

Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW.

Clin Infect Dis. 2009 Jul 15;49(2):205-12. doi: 10.1086/599827.

PMID:
19508165
17.

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.

Demczuk WH, Martin I, Griffith A, Lefebvre B, McGeer A, Lovgren M, Tyrrell GJ, Desai S, Sherrard L, Adam H, Gilmour M, Zhanel GG; Toronto Bacterial Diseases Network; Canadian Public Health Laboratory Network.

Can J Microbiol. 2013 Dec;59(12):778-88. doi: 10.1139/cjm-2013-0614. Epub 2013 Oct 21.

PMID:
24313450
18.

Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.

Muñoz-Almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolome R, Sauca G, Gallés C, Morta M, Ballester F, Raga X, Selva L; Catalan study group of invasive pneumococcal disease.

J Infect. 2011 Aug;63(2):151-62. doi: 10.1016/j.jinf.2011.06.002. Epub 2011 Jun 12.

PMID:
21679725
19.

Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.

Motlova J, Benes C, Kriz P.

Epidemiol Infect. 2009 Apr;137(4):562-9. doi: 10.1017/S0950268808001301. Epub 2008 Sep 16.

PMID:
18796171
20.

Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.

Foster D, Knox K, Walker AS, Griffiths DT, Moore H, Haworth E, Peto T, Brueggemann AB, Crook DW; Oxford Invasive Pneumococcal Surveillance Group.

J Med Microbiol. 2008 Apr;57(Pt 4):480-7. doi: 10.1099/jmm.0.47690-0.

PMID:
18349369

Supplemental Content

Support Center